Carson Wealth (CWM LLC)
VRCA icon

Carson Wealth (CWM LLC)’s Verrica Pharmaceuticals VRCA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56
Closed – – 5668
2025
Q3 		$0 Sell
56
-306
-85% -$1.84K ﹤0.01% 5569
2025
Q2 		$2K Sell
362
-39
-10% -$210 ﹤0.01% 4940
2025
Q1 		$2K Buy
401
+337
+527% +$2.18K ﹤0.01% 4827
2024
Q4 		$0 Buy
64
+62
+3,100% +$681 ﹤0.01% 5189
2024
Q3 		$0 Buy
2
+1
+100% +$45 ﹤0.01% 5186
2024
Q2 		$0 Buy
+1
New +$77 ﹤0.01% 4980
2024
Q1 		– Hold
0
– – – 4788
2022
Q2 		– Sell
-6
Closed – – 4116
2022
Q1 		$0 Buy
+6
New +$494 ﹤0.01% 3893

Other funds holding VRCA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Carson Wealth (CWM LLC)'s VRCA Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Verrica Pharmaceuticals (VRCA) in Q4 2025, closing a stake of 56 shares.

Carson Wealth (CWM LLC) first reported a position in VRCA in Q1 2022 and held it in 7 quarters. The position peaked at $2K in Q2 2025. 50 funds tracked by Wall St. Rank hold VRCA as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Verrica Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 56 Verrica Pharmaceuticals shares in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in Verrica Pharmaceuticals in Q1 2022 and held it in 7 quarters.
  • Carson Wealth (CWM LLC)'s Verrica Pharmaceuticals position peaked at $2K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.